Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall

Shock

Volumn 37, Issue 3, 2012, Pages 297-305

  Chang, Marisol ^a   Kistler, Erik B ^a   Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

BWVbody weight; LD50 oralVoral lethal dose; NSVnormal saline; SAOVsplanchnic arterial occlusion; TAVtranexamic acid

Indexed keywords

ISOPROTEIN; MUCIN; PROTEINASE; TRANEXAMIC ACID; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELIAC ARTERY STENOSIS; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; GASTROINTESTINAL MUCOSA; IMMUNOHISTOCHEMISTRY; INTESTINE ISCHEMIA; INTESTINE WALL; MALE; NONHUMAN; PROTEIN DOMAIN; PROTEINASE INHIBITION; RAT; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; WESTERN BLOTTING; WISTAR RAT; ZYMOGRAPHY;

ANIMALS; CADHERINS; CELIAC ARTERY; CHYMOTRYPSIN; CONSTRICTION, PATHOLOGIC; INTESTINAL MUCOSA; INTESTINES; ISCHEMIA; MALE; MESENTERIC ARTERIES; MUCINS; PANCREATIC ELASTASE; PROTEASE INHIBITORS; RATS; RATS, WISTAR; SPLANCHNIC CIRCULATION; TRANEXAMIC ACID; TRYPSIN;

EID: 84857565807     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318240b59b     Document Type: Article

References (35)

1. Perry JF, Smith GA, Yonehiro EG: Intestinal obstruction caused by adhesions; a review of 388 cases. Ann Surg 142(5):810-816, 1955.
2. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD: Acute mesenteric ischemia: a clinical review. Arch Intern Med 164(10):1054-1062, 2004. (Pubitemid 38668984)
3. Garofalo M, Borioni R, Nardi P, Turani F, Bertoldo F, Forlani S, Pellegrino A, Chiariello L: Early diagnosis of acute mesenteric ischemia after cardiopulmonary bypass. J Cardiovasc Surg 43(4):455-459, 2002.
4. Cheadle WG, Garr EE, Richardson JD: The importance of early diagnosis of small bowel obstruction. Am Surg 54(9):565-569, 1988.
5. World Health Organization: World Health Statistics Annual. 2008. Geneva, Switzerland: WHO Press, 2008.
6. Jones H, Trueman E: National Safety Council: accident facts. J Exp Biol 52(1): 201-216, 1996.
7. Holcomb J, Caruso J, McMullin N, Wade CE, Pearse L, Oetjen-Gerdes L, Champion HR, Lawnick M, Farr W, Rodriguez S, et al.: Causes of death in US Special Operations Forces in the global war on terrorism: 2001-2004. US Army Med Dep J JanYMar: 24-37, 2007.
8. Deitch EA, Xu DZ, Franko L, Ayala A, Chaudry IH: Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagicshock. Shock 1(2):141-146, 1994.
9. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, Leroy J, Thuillez C, Lebreton JP: Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol Gastrointest Liver Physiol 36(2):G314YG321, 1997.
10. Wattanasirichaigoon S, Menconi M, Delude R, Fink M: Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 12(2):127, 1999.
11. Sutherland NG, Bounous G, Gurd FN: Role of intestinal mucosal enzymes in the pathogenesis of shock. J Trauma 8(3):350-380, 1968.
12. Mitsuoka H, Kistler EB, Schmid-Schönbein GW: Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes. Proc Natl Acad Sci USA 97(4):1772-1777, 2000. (Pubitemid 30118518)
13. Waldo SW, Rosario HS, Penn AH, Schmid-Schönbein GW: Pancreatic digestive enzymes are potent generators of mediators for leukocyte activation and mortality. Shock 20(2):138-143, 2003.
14. Deitch E, Shi H, Lu Q, Feketeova E, Xu D: Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury. Shock 19(5):452, 2003.
15. Mitsuoka H, Schmid-Schönbein GW: Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure. Shock 14(5):522-527, 2000.
16. Fitzal F, DeLano F, Young C, Rosario H, Schmid-Schönbein G: Pancreatic protease inhibition during shock attenuates cell activation and peripheral inflammation. J Vasc Res 39(4):320-329, 2000. (Pubitemid 34983863)
17. Penn A, Schmid-Schönbein G: The intestine as source of cytotoxic mediators in shock: free fatty acids and degradation of lipid-binding proteins. Am J Physiol Heart Circ Physiol 294(4):H1779, 2008.
18. Bansil R, Stanley E, LaMont JT: Mucin biophysics. Annu Rev Physiol 57: 635-657, 1995.
19. Bush KT, Tsukamoto T, Nigam SK: Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol 278(5):F847YF852, 2000. (Pubitemid 30351088)
20. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, Lu Q, Xu da Z, Deitch EA: Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141(4):481-489, 2007. (Pubitemid 46441309)
21. Haglund U, Abe T, Ahren C, Braide I, Lundgren O: The intestinal mucosal lesions in shock. I. Studies on the pathogenesis. Eur Surg Res 8(5):435-447, 1976.
22. Andersson L, Nilsson IM, Niléhn JE, Hedner U, Granstrand B, Melander B: Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p aminomethyl cyclohexane carboxylic acid. Scand J Haematol 2(3): 230-247, 1965.
23. Dubber AHC, McNicol G, Douglas A: Amino methyl cyclohexane carboxylic acid (AMCHA), a new synthetic fibrinolytic inhibitor. Br J Haematol 11(2):237-245, 1965.
24. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor, New York: CSHL Press, 1988.
25. Zimmerman M, Ashe B, Yurewicz EC, Patel G: Sensitive assays for trypsin, elastase, and chymotrypsin using new fluorogenic substrates. Anal Biochem 78(1):47-51, 1977. (Pubitemid 8060691)
26. Castillo MJ, Nakajima K, Zimmerman M, Powers JC: Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases. Anal Biochem 99(1):53-64, 1979. (Pubitemid 10197705)
27. Zimmerman M, Yurewicz E, Patel G: A new fluorogenic substrate for chymotrypsin. Anal Biochem 70(1):258-262, 1976.
28. Rosario HS, Waldo SW, Becker SA, Schmid-Schönbein GW: Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am J Pathol 164(5):1707-1716, 2004. (Pubitemid 38529773)
29. Yi CF, Gosiewska A, Burtis D, Geesin J: Incorporation of fluorescent enzyme substrates in agarose gel for in situ zymography. Anal Biochem 291(1):27-33, 2001. (Pubitemid 32324521)
30. Gawlak M, Gorkiewicz T, Gorlewicz A, Konopacki FA, Kaczmarek L, Wilczynski GM: High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 158(1):167-176, 2009.
31. Hibbs M, Hasty K, Seyer J, Kang A, Mainardi C: Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260(4):2493, 1985.
32. Nilsson IM: Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol 33(Suppl 14):41, 1980.
33. Dunn CJ, Goa KL: Tranexamic acid: a review of its use in surgery and other indications. Drugs 57(6):1005-1032, 1999. (Pubitemid 29313210)
34. Fitzal F, DeLano F, Young C, Rosario H, Junger W, Schmid-Schönbein G: Pancreatic enzymes sustain systemic inflammation after an initial endotoxin challenge. Surgery 134(3):446-456, 2003. (Pubitemid 37215150)
35. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB: Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 158(2):444-451, 1998. (Pubitemid 28378171)